Memantine benefits functional abilities in moderate to severe Alzheimer’s disease

被引：0
|
作者：
Bengt Winblad
S. Gauthier
D. Åström
K. Stender
机构：
[1] Alzheimer Disease Research Center (KI-ADRC) NOVUM,Karolinska Institutet
[2] Douglas Institute for Mental Health,McGill Center for Studies in Aging
[3] H. Lundbeck A/S,Karolinska Institutet
[4] Alzheimer Disease Research Center (KI-ADRC) NOVUM,undefined
来源：
The journal of nutrition, health & aging | 2010年 / 14卷
关键词：
Memantine; Alzheimer’s disease; functional ability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：770 / 774
页数：4
相关论文
共 50 条
  • [31] Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
    Howard, Robert
    McShane, Rupert
    Lindesay, James
    Ritchie, Craig
    Baldwin, Ashley
    Barber, Robert
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Hughes, Alan
    Jacoby, Robin
    Jones, Rob
    Jones, Roy
    McKeith, Ian
    Macharouthu, Ajay
    O'Brien, John
    Passmore, Peter
    Sheehan, Bart
    Juszczak, Edmund
    Katona, Cornelius
    Hills, Robert
    Knapp, Martin
    Ballard, Clive
    Brown, Richard
    Banerjee, Sube
    Onions, Caroline
    Griffin, Mary
    Adams, Jessica
    Gray, Richard
    Johnson, Tony
    Bentham, Peter
    Phillips, Patrick
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 893 - 903
  • [32] Size estimates in the treatment of moderate to severe Alzheimer's disease with memantine
    Vercelletto, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S381 - S381
  • [33] Response to memantine treatment in moderate to severe Alzheimer's disease.
    van Dyck, C
    Ferris, S
    Graham, S
    Stoeffler, A
    Olin, J
    Wirth, Y
    Tariot, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S155 - S155
  • [34] Memantine in moderate to severe Alzheimer's disease:: An analysis of individual response
    Ferris, S. H.
    Stoeffler, A.
    Wirth, Y.
    Reisberg, B.
    Moebius, H. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 38 - 38
  • [35] Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer's disease?
    Doggrell, S
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (10) : 1857 - 1860
  • [36] Effect of memantine on behavioral outcomes in moderate to severe Alzheimer's disease
    Cummings, JL
    Schneider, E
    Tariot, PN
    Graham, SM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S127 - S127
  • [37] Memantine positively influences behaviour in moderate to severe Alzheimer's disease
    Möbius, HJ
    Stöffler, A
    Wirth, Y
    Gauthier, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S19 - S19
  • [38] Memantine A Review of its Use in Moderate to Severe Alzheimer's Disease
    McKeage, Kate
    CNS DRUGS, 2009, 23 (10) : 881 - 897
  • [39] Functional communication in patients with moderate Alzheimer's disease treated with memantine
    Graham, S.
    Tocco, M.
    Hendrix, S.
    Hofbauer, R. K.
    Perhach, J. L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S557 - S558
  • [40] Effects of Memantine on Language and Functional Communication in Patients with Moderate to Severe Alzheimer's Disease: A Pooled Analysis
    Tocco, Michael
    Saxton, Judith
    Hofbauer, Robert K.
    Graham, Stephen M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A78 - A79
12345